Dozyfyle M SR Tablet is a specialized formulation combining doxofylline (400 mg) and montelukast (10 mg), designed to effectively manage respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Doxofylline is a bronchodilator that helps relax and open the airways, facilitating easier breathing, while montelukast is a leukotriene receptor antagonist that reduces inflammation and bronchoconstriction. Together, these active ingredients work synergistically to provide relief from symptoms and improve overall lung function.
The sustained-release formulation of Dozyfyle M SR Tablet ensures a gradual release of the medication over time, allowing for once-daily dosing. This not only enhances patient compliance but also provides extended therapeutic effects, making it a convenient choice for individuals with chronic respiratory conditions. It is important for patients to follow the prescribed dosage to achieve optimal results and manage their symptoms effectively.
Patients using Dozyfyle M SR Tablet may experience side effects, which can vary in intensity. Common side effects may include headache, dizziness, gastrointestinal discomfort, and fatigue. More serious side effects, though rare, could involve allergic reactions or cardiovascular issues. It is essential for patients to report any unusual symptoms to their healthcare provider promptly.
For optimal storage, keep Dozyfyle M SR Tablet in a cool, dry place away from direct sunlight and moisture. Ensure that the medication is out of reach of children to prevent accidental ingestion.